Pharmaceutical & Medical Devices

Chaffe McCall represents a broad range of pharmaceutical and medical device manufacturers as regional and local counsel.  Our understanding of pharmaceutical and medical devices complex litigation and technology allows our team to work efficiently with our clients to develop strategies for effectively resolving matters.  Additionally, our representation of pharmaceutical clients has led to representation of related entities in matters involving agricultural science and veterinary science.

We counsel and defend our pharmaceutical and medical device clients in numerous areas including:

  • Personal injury claims involving use of pharmaceuticals and medical devices, including multi-district litigation matters
  • Mass torts and class actions
  • State Attorney General sponsored litigation
  • Tradename protection
  • Pricing litigation
  • Environmental claims

Chaffe McCall develops the best cost-benefit solution to meet the client’s business goals, which may include litigation, mediation, or settlement negotiations.  Our attorneys are experienced trial lawyers, who are skilled in all methods of dispute resolution and have a reputation for successfully handling the most challenging cases. Consistent with our firm’s theme, our Pharmaceutical and Medical Device practice is “Devoted to Excellence.”

Examples of representations and our successes:

  • In re Zyprexa Products Liability Litigation, MDL 1596 (Chaffe McCall successfully represented Eli Lilly in numerous claims by individuals who claimed that ingestion of Zyprexa caused personal injuries and claims by the Louisiana Attorney General for alleged consumer protection violations.)
  • In re Baycol Products Liability Litigation, MDL 1431 (Chaffe McCall represented Bayer Corporation in successfully resolving hundreds of claims by individuals who claimed injuries as a result of ingestion of Baycol, many of which were dismissed by summary judgment)In re Genetically Modified Rice Litigation,MDL 1811 (Chaffe McCall served as co-trial counsel for Bayer CropScience L.P. in Bellwether claims by rice farmers for alleged contamination of the United States rice supply.)
  • In re Phenylpropanolamine (PPA) Products Liability Litigation, MDL 1407 (Chaffe McCall represented Bayer Corporation in claims by thousands of Louisiana residents who claimed that ingestion of PPA caused their strokes.  The vast majority of those cases were dismissed before trial with favorable settlements in others.)
  • In re Boston Scientific Corp. Pelvic Repair System Products Liability Litigation, MDL 2326 (Chaffe McCall currently represents Boston Scientific Corporation as Louisiana counsel in medical device multi-district litigation.)
  • Smith v. Cutter Biological, 770 So. 2d 392 (La. App. 4th Cir. 2000) (Chaffe McCall was part of the trial team that secured dismissal of plaintiff’s Factor VIII litigation claim based on a limitations defense.)

Representative Clients

Abbott Laboratories
Allergan, Inc.
Bayer Corporation
Boston Scientific Corporation
Eli Lilly and Company
Guidant Corporation
Laboratory Corporation of America
Novo Nordisk, Inc.
NuVasive, Inc.
Purdue Pharma L.P.

Featured News

  • Chambers USA 2020 Rankings Announced

    Chambers USA Recognizes Chaffe McCall Attorneys with Top 2020 Rankings April 27, 2020 Chaffe McCall is pleased to announce that attorneys from its New Orleans and Houston offices have been recognized as “Leaders in Their Field” in the 2020 Chambers USA:…More»

  • Firm Mourns the Passing of Former Chaffe McCall Partner Robert Bryan Deane

    Longtime partner Robert “Bob” Deane, an integral member of Chaffe McCall’s Marine and Admiralty practice, passed away on May 1, 2020.  Bob joined Chaffe McCall in 1959 and practiced in the firm’s New Orleans office for over 42 years.   At Chaffe McCall, Bob had an outstanding legal career in litigation,  focusing his…More»

  • United States Supreme Court Decision on Safe Berth Clause

    Recently, the United States Supreme Court issued its long-anticipated decision in CITGO Asphalt Refining Co. v. Frescati Shipping Co., Ltd.(“ATHOS I”). In a 7-2 majority opinion, the Court affirmed the judgment of the 3rd U.S. Circuit Court of Appeals, holding a safe berth clause…More»

  • Chaffe McCall Responds to the COVID‐19 Outbreak

    Chaffe McCall remains open and operating at full strength. To our valued clients, friends, and colleagues: We hope that you and your loved ones remain healthy and safe during the COVID-19 pandemic.  Despite this unusual and highly complex environment, Chaffe McCall is…More»